MeiraGTx Holdings Debt 2024

MeiraGTx Holdings Aktienanalyse

What does MeiraGTx Holdings do?

MeiraGTx Holdings PLC is a leading company in the field of gene therapy and develops innovative therapies for various genetic diseases. The company was founded in 2015 and is headquartered in London, UK, with additional locations in the USA. MeiraGTx aims to change lives by developing gene therapy-based drugs that enable a cure or permanent relief from serious illnesses. History: MeiraGTx was founded by renowned genome researcher Dr. Gregory A. Petsko and an experienced team of scientists and experts in the biotechnology and pharmaceutical fields. With an experienced team and significant investment capital, MeiraGTx has established itself as a leading company in the field of gene therapy. Business model: MeiraGTx has a unique business model based on an innovative platform technology that enables the company to develop gene therapies for various diseases. The company works with a variety of technologies, including AAV vectors, DNA targeted integration, gene editing platform, and more. By combining these technologies, MeiraGTx can develop gene therapies tailored to the individual's condition. Segments: MeiraGTx consists of various divisions and products that focus on the development of therapeutics for various genetic diseases. Ophthalmology: MeiraGTx develops gene therapies for retinal diseases such as retinitis pigmentosa and macular degeneration. These therapies have the potential to preserve or even improve vision. Neurology: MeiraGTx develops therapeutics for neurological diseases such as Parkinson's and Huntington's. These gene therapies have the potential to alleviate the symptoms of the disease and improve the patient's quality of life. Hemophilia: MeiraGTx has developed gene therapies for hemophilia A and B based on its gene editing platform technology. These therapies have the potential to significantly improve the lives of hemophilia patients. Other products and therapies: MeiraGTx is also working on the development of gene therapies for cancer, cystic fibrosis, cardiovascular diseases, and autoimmune diseases. Summary: MeiraGTx is a leading company in the field of gene therapy and is committed to developing innovative therapeutics for various genetic diseases. With the help of technologies such as AAV vectors, DNA targeted integration, gene editing platform, and more, the company has the potential to change the lives of millions of patients. MeiraGTx is on track to revolutionize the healthcare industry, and it will be exciting to see what future advances the company will achieve. MeiraGTx Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding MeiraGTx Holdings's Debt Structure

MeiraGTx Holdings's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing MeiraGTx Holdings's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to MeiraGTx Holdings’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in MeiraGTx Holdings’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about MeiraGTx Holdings Stock

What is the debt of MeiraGTx Holdings this year?

MeiraGTx Holdings has a debt level of -57.45 USD this year.

What was the debt of MeiraGTx Holdings compared to the previous year?

The debt of MeiraGTx Holdings has increased by 29.09% compared to the previous year increased.

What are the consequences of high debt for investors in MeiraGTx Holdings?

High debt can pose a risk for investors of MeiraGTx Holdings, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of MeiraGTx Holdings?

Low debt means that MeiraGTx Holdings has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from MeiraGTx Holdings affect the company?

An increase in debt of MeiraGTx Holdings can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of MeiraGTx Holdings affect the company?

A reduction in debt of MeiraGTx Holdings can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of MeiraGTx Holdings?

Some factors that can influence the debt of MeiraGTx Holdings include investments, acquisitions, operating costs, and revenue development.

Why are the debts of MeiraGTx Holdings so important for investors?

The debts of MeiraGTx Holdings are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can MeiraGTx Holdings take to change the debt?

To change the debt, MeiraGTx Holdings can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does MeiraGTx Holdings pay?

Over the past 12 months, MeiraGTx Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MeiraGTx Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of MeiraGTx Holdings?

The current dividend yield of MeiraGTx Holdings is .

When does MeiraGTx Holdings pay dividends?

MeiraGTx Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of MeiraGTx Holdings?

MeiraGTx Holdings paid dividends every year for the past 0 years.

What is the dividend of MeiraGTx Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is MeiraGTx Holdings located?

MeiraGTx Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von MeiraGTx Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of MeiraGTx Holdings from 6/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/21/2024.

When did MeiraGTx Holdings pay the last dividend?

The last dividend was paid out on 6/21/2024.

What was the dividend of MeiraGTx Holdings in the year 2023?

In the year 2023, MeiraGTx Holdings distributed 0 USD as dividends.

In which currency does MeiraGTx Holdings pay out the dividend?

The dividends of MeiraGTx Holdings are distributed in USD.